Synthetic Antigens and Vaccines

  • Ruth Arnon
Part of the NATO ASI Series book series (NSSA, volume 179)


Early studies in our laboratory have demonstrated that synthetic antigens containing an immunoreactive region of a protein can give rise to a specific, and often conformation-dependent, immune response towards the intact native protein (Arnon et al, 1971). When the protein in question is a component of a virus e.g. the coat protein of MS-2 coliphage, the antibodies induced by a synthetic fragment were capable of neutralizing the viability of the phage (Langbeheim et al, 1976). These findings paved the way for the study of synthetic vaccines. We have employed this approach for the study of three systems — the influenza virus and the bacterial toxins of cholera and shigella. The results achieved to date as well as the future prospects of these three synthetic vaccines are discussed below.


Influenza Virus Synthetic Peptide Cholera Toxin Tetanus Toxoid Antigenic Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ada, G.L., Leung, K.N. and Ertl, H., 1981, An analysis of effector T-cell generation and function in mice exposed to influenza A or Sendai viruses, Immun.Rev., 58: 5.PubMedCrossRefGoogle Scholar
  2. Arnon, R., Maron, E., Sela, M. and Anfinsen, C.B., 1971, Antibodies reactive with native lysozyme elicited by a completely synthetic antigen, Proc. Natl. Acad. Sci. USA, 68: 1450.PubMedCrossRefGoogle Scholar
  3. Arnon, R., Sela, M., Parant, M. and Chedid, L., 1980, Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity, Proc. Natl. Acad. Sci.USA., 77: 6769.PubMedCrossRefGoogle Scholar
  4. Audibert, F., Jolivet, M., Chedid, L., Alouf, J.E., Boquet, P., Rivaille, P. and Siffert, O., 1981, Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide, Nature, 289: 593.PubMedCrossRefGoogle Scholar
  5. Audibert, F., Jolivet, M., Chedid, L., Arnon. R., Sela, M., 1982, Successful immunization with a totally synthetic diphtheria vaccine, Proc.Natl. Acad.Sci.USA, 79: 5042.PubMedCrossRefGoogle Scholar
  6. Carelli, C., Audibert, F., Faillard, J. and Chedid, L., 1982, Immunological castration of male mice by a totally synthetic vaccine (LH-RH conjugated to MDP-lysine) administered in saline, Int.J. Immunopharmacol., 4: 290.CrossRefGoogle Scholar
  7. Ellouz, F., Adam, A., Ciorbaru, R. and Lederer, E., 1974, Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives, Biochim.Biophys.Res.Commun., 55: 1317.CrossRefGoogle Scholar
  8. Harari, I., Donohue-Rolfe, A., Keusch, G, and Arnon, R., 1988, Synthetic peptides of Shiga Toxin B subunit induce antibodies which neutralize its biological activity, Infect. and Immun., 56: 1618.Google Scholar
  9. Jackson, D.C., Murray, J.M., White, D.O., Fagan, C.N. and Tregear, G.W., 1982, Antigenic activity of a synthetic peptide corresponding to the loop region of influenza virus hemagglutin, Virology, 120: 273.PubMedCrossRefGoogle Scholar
  10. Jacob, CO., Sela, M. and Arnon, R., 1983, Antibodies against synthetic peptides of the B subunit of cholera toxin: cross reaction and neutralization of the toxin, Proc. Natl. Acad. Sci. USA, 80: 7611.PubMedCrossRefGoogle Scholar
  11. Jacob, C.O., Sela, M., Pines, M., Hurwitz, S. and Arnon, R., 1984a, Adenylate cyclase activation by cholera toxin as well as its activity are inhibited with antibodies against related synthetic peptides, Proc. Natl.Acad.Sci.USA, 8: 7893.CrossRefGoogle Scholar
  12. Jacob, C.O., Pines, M. and Arnon, R., 1984b, Neutralization of heat labile toxin of E. coli by antibodies to synthetic peptides derived from B subunit of cholera toxin, EMBO J., 3: 2889.PubMedGoogle Scholar
  13. Jacob, C.O., Leitner, M., Zamir, A., Salomon, D. and Arnon, R., 1985, Priming immunization against cholera toxin and E. coli heat-labile toxin by a cholera toxin short peptide-β-galactosidase hybrid synthesized in E. coli, EMBO J., 4: 3339.PubMedGoogle Scholar
  14. Jacob, C.O., Grossfeld, S., Sela, M. and Arnon, R., 1986, Priming immune response to cholera toxin induced by synthetic peptides, Eur.J. Immun., 16: 1057.CrossRefGoogle Scholar
  15. Langbeheim, H., Arnon, R. and Sela, M., 1976, Antiviral effect on MS-2 coliphage obtained with a synthetic antigen, Proc. Natl. Acad. Sci. USA, 73: 4636.PubMedCrossRefGoogle Scholar
  16. Laver, W.G., Air, C.M., 1979, “Structure and variation in influenza virus”, Elsevier, North Holland, Amsterdam.Google Scholar
  17. Lindhom, L., Holmgren, J., Wikstrom, M., Karlsonn, V., Andersson, K. and Lycke, N., 1983, Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin, Infect.Immun., 40: 570.Google Scholar
  18. Muller, C.M., Shapira, M. and Arnon, R., 1982, Anti-influenza response achieved by immunization with a synthetic conjugate, Proc. Natl. Acad. Sci.USA, 79: 569.PubMedCrossRefGoogle Scholar
  19. Seidah, N.C., Donohue-Rolfe, A., Lazure, C., Auclair, A., Keusch, G.T. and Chretien, M., 1986, Complete amino acid sequence of Shigella toxin B-chain, J.Biol.Chem., 261: 13928.PubMedGoogle Scholar
  20. Shapira, M., Jibson, M., Muller, CM. and Arnon, R., 1984, Immunity and protection against influenza virus by a synthetic peptide corresponding to antigenic sites of hemagglutinin, Proc.Natl.Acad.Sci.USA, 81: 2461.PubMedCrossRefGoogle Scholar
  21. Shapira, M., Jolivet, M. and Arnon, R., 1985, Synthetic vaccine against influenza with built-in adjuvanticity, Int. J. Immunopharmacol., 7: 719.PubMedCrossRefGoogle Scholar
  22. Wiley, D.C, Wilson, I.A. and Skehel, J.J., 1981, Structural identifications of the antibody binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variation, Nature, 289: 373.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Ruth Arnon
    • 1
  1. 1.Department of Chemical ImmunologyThe Weizmann Institute of ScienceRehovotIsrael

Personalised recommendations